Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

Shares of Hims & Hers closed 5.1% higher after the company said it will expand its weight-loss offerings ... Wegovy and diabetes drug Ozempic, both known chemically as semaglutide, from its ...

Fields was prescribed a compounded weight loss drug containing the active ingredient semaglutide that she could purchase for $199 a month from the website Hims & Hers. Fields said she’s since ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

Hims & Hers took a hit when the Food and Drug Administration (FDA) announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply.

Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings ... by the Food and Drug Administration (FDA), which removed semaglutide — the ...

Shares of Hims & Hers closed 5.1% higher after the company said it will expand its weight-loss offerings ... Wegovy and diabetes drug Ozempic, both known chemically as semaglutide, from its ...

Hims & Hers offers both branded and cheaper versions of Novo's weight-loss drug Wegovy ... selling Wegovy and diabetes drug Ozempic, both known chemically as semaglutide, from its shortage ...